Publication Name	World Journal of Gastroenterology
Manuscript ID	6527
Country	China

Received	2013-10-22 17:56
Peer-Review Started	2013-10-23 17:46
To Make the First Decision	2014-01-09 13:43
Return for Revision	2014-01-10 10:47
Revised
Second Decision	2014-05-29 20:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-05-29 20:56
Articles in Press	2014-05-29 21:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-08-18 16:11
Publish the Manuscript Online	2014-09-07 13:31

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Towards personalized perioperative treatment for advanced gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Ru-Lin Miao and Ai-Wen Wu
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81071983 Beijing High-level Talents Project (2013)
Corresponding Author	Ai-Wen Wu, MD, PhD, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Gastrointestinal Surgery, Peking University Cancer Hospital, Beijing Cancer Hospital and Institute, Fucheng Road No. 52, Haidian District, Beijing 100142, China. wuaw@sina.com
Key Words	Gastric cancer; Pre-therapeutic evaluation; Perioperative chemotherapy; Perioperative radiochemotherapy; Perioperative target therapy
Core Tip	Multimodal perioperative treatment of advanced gastric cancer is playing an increasingly important role in patient treatment. Different strategies, including preoperative and postoperative chemotherapy and radiochemotherapy, are implemented in clinical practice and a new concept of perioperative-targeted therapy is emerging. Although many randomized clinical trials have been performed to determine the effectiveness of these therapies over surgery alone, little evidence exists regarding the comparison of the different therapies. Personalized treatment should be based on the results of randomized clinical trials as well as subgroup analyses, tailored by histology, demography, and predictors, including tumor markers and genomic profiling.
Publish Date	2014-09-07 13:31
Citation	Miao RL, Wu AW. Towards personalized perioperative treatment for advanced gastric cancer. World J Gastroenterol 2014; 20(33): 11586-11594
URL	http://www.wjgnet.com/1007-9327/full/v20/i33/11586.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i33.11586

Full Article (PDF)	WJG-20-11586.pdf
Full Article (Word)	WJG-20-11586.doc
Manuscript File	6527-Review.docx
Answering Reviewers	6527-Answering reviewers.pdf
Copyright License Agreement	6527-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6527-Language certificate.pdf
Peer-review Report	6527-Peer review(s).pdf
Scientific Misconduct Check	6527-CrossCheck.jpg
Scientific Editor Work List	6527-Scientific editor work list.pdf